A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors
NCT00708006
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
HGS1029
Sponsor
Human Genome Sciences Inc.